Log In
Print this Print this

Equa, Galvus, Xiliarx, vildagliptin

Also known as: Jalra (formerly LAF237)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionDipeptidyl peptidase-4 (DPP-4) inhibitor
Molecular Target Dipeptidyl peptidase-4 (DPP-4) (CD26)
Mechanism of ActionDipeptidyl peptidase (DPP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes; Treat Type II diabetes in patients with moderate or severe renal impairment
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today